These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 8540700

  • 1. DNA gyrase gyrA mutations in quinolone-resistant clinical isolates of Pseudomonas aeruginosa.
    Yonezawa M, Takahata M, Matsubara N, Watanabe Y, Narita H.
    Antimicrob Agents Chemother; 1995 Sep; 39(9):1970-2. PubMed ID: 8540700
    [Abstract] [Full Text] [Related]

  • 2. Cloning and nucleotide sequence of Pseudomonas aeruginosa DNA gyrase gyrA gene from strain PAO1 and quinolone-resistant clinical isolates.
    Kureishi A, Diver JM, Beckthold B, Schollaardt T, Bryan LE.
    Antimicrob Agents Chemother; 1994 Sep; 38(9):1944-52. PubMed ID: 7811002
    [Abstract] [Full Text] [Related]

  • 3. Type II topoisomerase mutations in fluoroquinolone-resistant clinical strains of Pseudomonas aeruginosa isolated in 1998 and 1999: role of target enzyme in mechanism of fluoroquinolone resistance.
    Akasaka T, Tanaka M, Yamaguchi A, Sato K.
    Antimicrob Agents Chemother; 2001 Aug; 45(8):2263-8. PubMed ID: 11451683
    [Abstract] [Full Text] [Related]

  • 4. Proportion of DNA gyrase mutants among quinolone-resistant strains of Pseudomonas aeruginosa.
    Yoshida H, Nakamura M, Bogaki M, Nakamura S.
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1273-5. PubMed ID: 2168149
    [Abstract] [Full Text] [Related]

  • 5. Analysis of the NH2-terminal 83rd amino acid of Escherichia coli GyrA in quinolone-resistance.
    Yonezawa M, Takahata M, Banzawa N, Matsubara N, Watanabe Y, Narita H.
    Microbiol Immunol; 1995 Jun; 39(4):243-7. PubMed ID: 7651238
    [Abstract] [Full Text] [Related]

  • 6. Detection of gyrA mutations among 335 Pseudomonas aeruginosa strains isolated in Japan and their susceptibilities to fluoroquinolones.
    Takenouchi T, Sakagawa E, Sugawara M.
    Antimicrob Agents Chemother; 1999 Feb; 43(2):406-9. PubMed ID: 9925546
    [Abstract] [Full Text] [Related]

  • 7. Cloning and nucleotide sequence of the Campylobacter jejuni gyrA gene and characterization of quinolone resistance mutations.
    Wang Y, Huang WM, Taylor DE.
    Antimicrob Agents Chemother; 1993 Mar; 37(3):457-63. PubMed ID: 8384814
    [Abstract] [Full Text] [Related]

  • 8. Ciprofloxacin and the fluoroquinolones. New concepts on the mechanism of action and resistance.
    Fisher LM, Lawrence JM, Josty IC, Hopewell R, Margerrison EE, Cullen ME.
    Am J Med; 1989 Nov 30; 87(5A):2S-8S. PubMed ID: 2574005
    [Abstract] [Full Text] [Related]

  • 9. GyrA mutations in ciprofloxacin-resistant clinical isolates of Pseudomonas aeruginosa in a Silesian Hospital in Poland.
    Wydmuch Z, Skowronek-Ciołek O, Cholewa K, Mazurek U, Pacha J, Kepa M, Idzik D, Wojtyczka RD.
    Pol J Microbiol; 2005 Nov 30; 54(3):201-6. PubMed ID: 16450835
    [Abstract] [Full Text] [Related]

  • 10. Quinolone resistance mutations in the DNA gyrase gyrA and gyrB genes of Staphylococcus aureus.
    Ito H, Yoshida H, Bogaki-Shonai M, Niga T, Hattori H, Nakamura S.
    Antimicrob Agents Chemother; 1994 Sep 30; 38(9):2014-23. PubMed ID: 7811012
    [Abstract] [Full Text] [Related]

  • 11. Detection of mutations in the gyrA and parC genes in quinolone-resistant clinical isolates of Enterobacter cloacae.
    Deguchi T, Yasuda M, Nakano M, Ozeki S, Kanematsu E, Nishino Y, Ishihara S, Kawada Y.
    J Antimicrob Chemother; 1997 Oct 30; 40(4):543-9. PubMed ID: 9372424
    [Abstract] [Full Text] [Related]

  • 12. Type II topoisomerase mutations in ciprofloxacin-resistant strains of Pseudomonas aeruginosa.
    Mouneimné H, Robert J, Jarlier V, Cambau E.
    Antimicrob Agents Chemother; 1999 Jan 30; 43(1):62-6. PubMed ID: 9869566
    [Abstract] [Full Text] [Related]

  • 13. Quinolone-resistant mutants of escherichia coli DNA topoisomerase IV parC gene.
    Kumagai Y, Kato JI, Hoshino K, Akasaka T, Sato K, Ikeda H.
    Antimicrob Agents Chemother; 1996 Mar 30; 40(3):710-14. PubMed ID: 8851598
    [Abstract] [Full Text] [Related]

  • 14. gyrA and parC mutations in quinolone-resistant clinical isolates of Pseudomonas aeruginosa from Nini Hospital in north Lebanon.
    Salma R, Dabboussi F, Kassaa I, Khudary R, Hamze M.
    J Infect Chemother; 2013 Feb 30; 19(1):77-81. PubMed ID: 22821356
    [Abstract] [Full Text] [Related]

  • 15. Detection of gyrA and gyrB mutations in quinolone-resistant clinical isolates of Escherichia coli by single-strand conformational polymorphism analysis and determination of levels of resistance conferred by two different single gyrA mutations.
    Ouabdesselam S, Hooper DC, Tankovic J, Soussy CJ.
    Antimicrob Agents Chemother; 1995 Aug 30; 39(8):1667-70. PubMed ID: 7486897
    [Abstract] [Full Text] [Related]

  • 16. Detection of 4-quinolone resistance mutation in gyrA gene of Shigella dysenteriae type 1 by PCR.
    Rahman M, Mauff G, Levy J, Couturier M, Pulverer G, Glasdorff N, Butzler JP.
    Antimicrob Agents Chemother; 1994 Oct 30; 38(10):2488-91. PubMed ID: 7840594
    [Abstract] [Full Text] [Related]

  • 17. Cloning and nucleotide sequence of the DNA gyrase gyrA gene from Serratia marcescens and characterization of mutations in gyrA of quinolone-resistant clinical isolates.
    Kim JH, Cho EH, Kim KS, Kim HY, Kim YM.
    Antimicrob Agents Chemother; 1998 Jan 30; 42(1):190-3. PubMed ID: 9449286
    [Abstract] [Full Text] [Related]

  • 18. Molecular mechanisms of fluoroquinolone resistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
    Jalal S, Ciofu O, Hoiby N, Gotoh N, Wretlind B.
    Antimicrob Agents Chemother; 2000 Mar 30; 44(3):710-2. PubMed ID: 10681343
    [Abstract] [Full Text] [Related]

  • 19. gyrA mutations in high-level fluoroquinolone-resistant clinical isolates of Escherichia coli.
    Conrad S, Oethinger M, Kaifel K, Klotz G, Marre R, Kern WV.
    J Antimicrob Chemother; 1996 Sep 30; 38(3):443-55. PubMed ID: 8889719
    [Abstract] [Full Text] [Related]

  • 20. Type II topoisomerase quinolone resistance-determining regions of Aeromonas caviae, A. hydrophila, and A. sobria complexes and mutations associated with quinolone resistance.
    Goñi-Urriza M, Arpin C, Capdepuy M, Dubois V, Caumette P, Quentin C.
    Antimicrob Agents Chemother; 2002 Feb 30; 46(2):350-9. PubMed ID: 11796341
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.